Home › Peptide glossary

Peptide glossary

Plain definitions of the words you will meet on labels, vials and forums, and where each compound stands with regulators.

In short

This glossary explains common peptide and GLP-1 terms in plain language. It gives no doses, and it is not medical advice. To see which compounds are approved, read the compound list.

Terms

Agonist
A substance that switches on a receptor in the body. GLP-1 medicines are GLP-1 receptor agonists: they act like the natural hormone.
Amylin
A hormone released with insulin that is involved in fullness. Pramlintide and cagrilintide are man-made versions.
Bacteriostatic water
Sterile water with a preservative that slows the growth of bacteria. It is often used to mix freeze-dried powders. Use what your product instructions call for.
Compounded medicine
A medicine a pharmacy makes for a patient, instead of an approved product. The FDA says compounded drugs do not go through its approval process, so it does not check their safety, effectiveness or quality before they reach the market.
Concentration
How much of a substance is in each mL of liquid, for example 5 mg/mL. It changes if you add a different amount of water to a vial, so write it down.
Dose escalation
Raising a dose in steps over time. Also called titration. The steps come from the label and your prescriber.
Elimination half-life
The time it takes for the amount of a medicine in the body to fall by half. The U.S. labels give about 1 week for semaglutide, and about 5 days for tirzepatide.
Eructation
The medical word for burping. It is the term used on GLP-1 labels.
GIP
Glucose-dependent insulinotropic polypeptide, a gut hormone. Tirzepatide acts on GIP and GLP-1 receptors.
GLP-1
Glucagon-like peptide-1, a gut hormone involved in blood sugar and appetite. Semaglutide and liraglutide act on its receptor.
Glucagon
A hormone that raises blood sugar. Retatrutide and survodutide are studied for acting on its receptor as well as GLP-1.
HbA1c
A blood test showing average blood sugar over about the past three months. Diabetes trials often report it.
Intramuscular
Into a muscle. Many hormone injections in oil are given this way.
Investigational
Being studied in clinical trials and not yet approved for general use.
Label
The official prescribing information for an approved medicine. In the U.S. you can read labels on DailyMed. It is the first place to check a fact about a medicine.
Lean mass
Everything in the body except fat, which includes muscle, water and organs. It is not the same as muscle.
Lyophilised
Freeze-dried into a powder, to be mixed with liquid before use. Many peptides are sold this way.
Maintenance dose
The dose a person stays on after any dose increases. It comes from the label and your prescriber.
mcg and mg
Both are units of weight. 1 mg is 1,000 mcg, so mixing them up is a 1,000-fold error. Write the unit next to every number.
Microdosing
An informal word for taking less than a labeled dose. It is not a term on the labels, and it is not a dose schedule from a regulator. Ask your prescriber.
Off-label
Using an approved medicine for a purpose, or in a way, that its label does not list.
Peptide
A short chain of amino acids, the building blocks of proteins. Some peptides are approved medicines, such as semaglutide, and many are not.
Placebo
A dummy treatment with no active medicine, used in trials to show what happens without the medicine.
Priming
Pushing a small amount of medicine through a pen before injecting, to clear air and check that it works. Follow your pen's instructions.
Reconstitution
Mixing a freeze-dried powder with a liquid to make a solution. See the reconstitution calculator.
Research use only
A label on products sold for laboratory work. It does not mean a product is approved or checked for use in people.
Secretagogue
A substance that prompts the body to release something. Growth hormone secretagogues prompt the release of growth hormone.
Steady state
When the amount of a medicine in the body settles into a regular pattern with repeat doses. The labels give about 4 to 5 weeks for weekly semaglutide on Ozempic, and 4 weeks for tirzepatide.
Subcutaneous
Under the skin. GLP-1 pens are injected this way, usually in the abdomen or thigh, or the upper arm for some products.
Titration
Changing a dose in steps until reaching the intended dose. See the titration planner.
U-100 syringe
A syringe marked so that 100 units equal 1 mL. Units measure volume on the syringe, not the amount of medicine. See the units calculator.
Vial
A small sealed bottle of medicine. Unlike a pen, the dose you draw depends on the strength on its label and your syringe. See the vial tracker.

Compounds

See the status of more than 50 compounds, from approved medicines to research chemicals.

Useful pages

Reko records what you and your prescriber decide. It never suggests a dose, and this page is not medical advice.

Sources
  1. U.S. labels on DailyMed: Ozempic, Mounjaro.
  2. U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers.

Your record, in one private place

Open every screen with an example record before you pay.

RekoFor iPhone and iPadDownload